These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Experience with ceftazidime in cystic fibrosis. Dodge J; Zamiri I; Goodchild M; Ingram P J Antimicrob Chemother; 1983 Jul; 12 Suppl A():325-9. PubMed ID: 6352637 [TBL] [Abstract][Full Text] [Related]
3. The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients. Walstad RA; Hellum KB; Svarva PL; Ingram PM J Antimicrob Chemother; 1983 Jul; 12 Suppl A():131-7. PubMed ID: 6352614 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of ceftazidime in Japan. Ishibiki K J Antimicrob Chemother; 1983 Jul; 12 Suppl A():123-30. PubMed ID: 6225760 [TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of ceftazidime in the field of pediatrics]. Koshinami M; Watanabe A Jpn J Antibiot; 1984 Mar; 37(3):344-8. PubMed ID: 6376847 [TBL] [Abstract][Full Text] [Related]
15. Trial of ceftazidime efficacy in respiratory infections at two dose levels. Feist H; Vetter N; Muhar F; Williams KJ; Brandstetter HJ; Ho I J Antimicrob Chemother; 1981 Sep; 8 Suppl B():299-301. PubMed ID: 19803002 [TBL] [Abstract][Full Text] [Related]
16. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis. Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788 [TBL] [Abstract][Full Text] [Related]
17. Drug resistant Haemophilus influenzae from respiratory tract infection in a tertiary care hospital in north India. Nag VL; Ayyagari A; Venkatesh V; Ghar M; Yadav V; Prasad KN Indian J Chest Dis Allied Sci; 2001; 43(1):13-7. PubMed ID: 11370501 [TBL] [Abstract][Full Text] [Related]
18. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies]. Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434 [No Abstract] [Full Text] [Related]
19. Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections. Clumeck N; Gordts B; Dab I; Jaspar N; Van Laethem Y; Butzler JP J Antimicrob Chemother; 1983 Jul; 12 Suppl A():207-11. PubMed ID: 6352620 [TBL] [Abstract][Full Text] [Related]
20. Ceftazidime in severe infections: a Swiss multicentre study. Francioli P; Clément M; Geroulanos S; von Graevenitz A; Luthy R; Regamey C; Stalder H; Vogt M; Waldvogel FA J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]